TY - JOUR

T1 - Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030

AU - Martelletti, Paolo

AU - Leonardi, Matilde

AU - Ashina, Messoud

AU - Burstein, Rami

AU - Cho, Soo Jin

AU - Charway-Felli, Augustina

AU - Dodick, David W.

AU - Gil-Gouveia, Raquel

AU - Grazzi, Licia

AU - Lampl, Christian

AU - MaassenVanDenBrink, Antoinette

AU - Minen, Mia T.

AU - Mitsikostas, Dimos Dimitrios

AU - Olesen, Jes

AU - Owolabi, Mayowa Ojo

AU - Reuter, Uwe

AU - Ruiz de la Torre, Elena

AU - Sacco, Simona

AU - Schwedt, Todd J.

AU - Serafini, Gianluca

AU - Surya, Nirmal

AU - Tassorelli, Cristina

AU - Wang, Shuu Jiun

AU - Wang, Yonggang

AU - Wijeratne, Tissa

AU - Raggi, Alberto

N1 - Publisher Copyright: © 2023, Springer-Verlag Italia S.r.l., part of Springer Nature.

PY - 2023

Y1 - 2023

N2 - The 2030 Agenda for Sustainable Development sets out, through 17 Sustainable Development Goals (SDGs), a path for the prosperity of people and the planet. SDG 3 in particular aims to ensure healthy lives and promote well-being for all at all ages and includes several targets to enhance health. This review presents a “headache-tailored” perspective on how to achieve SDG 3 by focusing on six specific actions: targeting chronic headaches; reducing the overuse of acute pain-relieving medications; promoting the education of healthcare professionals; granting access to medication in low- and middle-income countries (LMIC); implementing training and educational opportunities for healthcare professionals in low and middle income countries; building a global alliance against headache disorders. Addressing the burden of headache disorders directly impacts on populations’ health, as well as on the possibility to improve the productivity of people aged below 50, women in particular. Our analysis pointed out several elements, and included: moving forward from frequency-based parameters to define headache severity; recognizing and managing comorbid diseases and risk factors; implementing a disease management multi-modal management model that incorporates pharmacological and non-pharmacological treatments; early recognizing and managing the overuse of acute pain-relieving medications; promoting undergraduate, postgraduate, and continuing medical education of healthcare professionals with specific training on headache; and promoting a culture that favors the recognition of headaches as diseases with a neurobiological basis, where this is not yet recognized. Making headache care more sustainable is an achievable objective, which will require multi-stakeholder collaborations across all sectors of society, both health-related and not health-related. Robust investments will be needed; however, considering the high prevalence of headache disorders and the associated disability, these investments will surely improve multiple health outcomes and lift development and well-being globally.

AB - The 2030 Agenda for Sustainable Development sets out, through 17 Sustainable Development Goals (SDGs), a path for the prosperity of people and the planet. SDG 3 in particular aims to ensure healthy lives and promote well-being for all at all ages and includes several targets to enhance health. This review presents a “headache-tailored” perspective on how to achieve SDG 3 by focusing on six specific actions: targeting chronic headaches; reducing the overuse of acute pain-relieving medications; promoting the education of healthcare professionals; granting access to medication in low- and middle-income countries (LMIC); implementing training and educational opportunities for healthcare professionals in low and middle income countries; building a global alliance against headache disorders. Addressing the burden of headache disorders directly impacts on populations’ health, as well as on the possibility to improve the productivity of people aged below 50, women in particular. Our analysis pointed out several elements, and included: moving forward from frequency-based parameters to define headache severity; recognizing and managing comorbid diseases and risk factors; implementing a disease management multi-modal management model that incorporates pharmacological and non-pharmacological treatments; early recognizing and managing the overuse of acute pain-relieving medications; promoting undergraduate, postgraduate, and continuing medical education of healthcare professionals with specific training on headache; and promoting a culture that favors the recognition of headaches as diseases with a neurobiological basis, where this is not yet recognized. Making headache care more sustainable is an achievable objective, which will require multi-stakeholder collaborations across all sectors of society, both health-related and not health-related. Robust investments will be needed; however, considering the high prevalence of headache disorders and the associated disability, these investments will surely improve multiple health outcomes and lift development and well-being globally.

KW - Global burden of disease study

KW - Low- and middle-income countries

KW - Medication overuse headache

KW - Migraine

KW - Sustainable development goals

KW - Tension-type headache

U2 - 10.1186/s10194-023-01666-2

DO - 10.1186/s10194-023-01666-2

M3 - Review

C2 - 37884869

AN - SCOPUS:85175021491

VL - 24

JO - Journal of Headache and Pain

JF - Journal of Headache and Pain

SN - 1129-2369

IS - 1

M1 - 140

ER -